CVSS2
Attack Vector
NETWORK
Attack Complexity
LOW
Authentication
NONE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
PARTIAL
AV:N/AC:L/Au:N/C:P/I:P/A:P
CVSS3
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
LOW
Integrity Impact
HIGH
Availability Impact
HIGH
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
AI Score
Confidence
High
EPSS
Percentile
80.2%
CVSS v3 9.4
ATTENTION: Exploitable remotely/low skill level to exploit
Vendor: Becton, Dickinson and Company (BD)
Equipment: Alaris GS, Alaris GH, Alaris CC, Alaris TIVA
Vulnerability: Improper Authentication
Successful exploitation of this vulnerability may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port. BD has determined the affected products are not sold within the United States.
The following versions of Alaris Plus, medical syringe pumps, Versions 2.3.6 and prior, are affected:
The software does not perform authentication for functionality that requires a provable user identity.
CVE-2018-14786 has been assigned to this vulnerability. A CVSS v3 base score of 9.4 has been calculated; the CVSS vector string is (AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H).
Elad Luz of CyberMDX discovered this vulnerability, and BD reported this vulnerability to NCICC.
BD reports that this vulnerability cannot be performed if the device is connected to an Alaris Gateway Workstation docking station. Also, an attacker cannot switch the device on remotely, and no PHI or PII can be accessed by exploiting this vulnerability.
BD recommends the following mitigations and compensating controls in order to reduce risk associated with this vulnerability:
For more information on BD’s product security and vulnerability management, contact their product security office at:
<http://www.bd.com/productsecurity>
NCCIC recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should:
NCCIC reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
NCCIC also provides a section for control systems security recommended practices on the ICS-CERT web page. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Additional mitigation guidance and recommended practices are publicly available on the ICS-CERT website in the Technical Information Paper, ICS-TIP-12-146-01B–Targeted Cyber Intrusion Detection and Mitigation Strategies.
Organizations observing any suspected malicious activity should follow their established internal procedures and report their findings to NCCIC for tracking and correlation against other incidents.
No known public exploits specifically target this vulnerability.
web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2018-14786
www.bd.com/productsecurity
cisasurvey.gov1.qualtrics.com/jfe/form/SV_9n4TtB8uttUPaM6?product=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-18-235-01
cwe.mitre.org/data/definitions/287.html
public.govdelivery.com/accounts/USDHSCISA/subscriber/new?topic_id=USDHSCISA_138
twitter.com/CISAgov
twitter.com/intent/tweet?text=BD%20Alaris%20Plus+https://www.cisa.gov/news-events/ics-medical-advisories/icsma-18-235-01
www.dhs.gov
www.dhs.gov/foia
www.dhs.gov/performance-financial-reports
www.facebook.com/CISA
www.facebook.com/sharer/sharer.php?u=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-18-235-01&title=BD%20Alaris%20Plus
www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
www.instagram.com/cisagov
www.linkedin.com/company/cybersecurity-and-infrastructure-security-agency
www.linkedin.com/sharing/share-offsite/?url=https://www.cisa.gov/news-events/ics-medical-advisories/icsma-18-235-01
www.oig.dhs.gov/
www.usa.gov/
www.whitehouse.gov/
www.youtube.com/@cisagov
mailto:?subject=BD%20Alaris%20Plus&body=www.cisa.gov/news-events/ics-medical-advisories/icsma-18-235-01
CVSS2
Attack Vector
NETWORK
Attack Complexity
LOW
Authentication
NONE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
PARTIAL
AV:N/AC:L/Au:N/C:P/I:P/A:P
CVSS3
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
LOW
Integrity Impact
HIGH
Availability Impact
HIGH
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
AI Score
Confidence
High
EPSS
Percentile
80.2%